DB cuts Stratec to 'hold', says margin progression at risk

Stratec SE

13/03/2023 08:48

** Deutsche Bank cuts German biomedical technology company
Stratec  SBSG.DE  to "hold" from "buy" citing increased
uncertainty around margin development following another profit
warning
    ** "Last week's profit warning was the third disappointment
in 12 months, which was clearly a setback for the investment
case," the broker says after the company posted on Thursday
preliminary FY results below expectations 
    ** DB also says cost-savings programme and extended price
increases are unlikely to be enough to win back investors' trust
    ** "Investment case could be treading water until the
company again proves that it can deliver on guidance without any
setbacks," the brokerage adds
    ** Out of nine analysts, three rate the stock "buy", five
rate it "hold" and one "sell"

 (Reporting by Anastasiia Kozlova)
 ((Anastasiia.Kozlova@thomsonreuters.com))